The CARES Initiative: A Global Initiative in Support of the Fight Against HIV & Related Co-infections
More than 30 years after HIV/AIDS first appeared, there are an estimated 37 million cases worldwide with nearly 70% of HIV+ patients living in Sub Saharan Africa followed by Southeast Asia, Latin America and Eastern Europe. The vast majority of individuals affected by HIV are in low and middle income countries. More than 3 million children were infected by HIV positive mothers during pregnancy, childbirth or breastfeeding(1).
“More than 3 million children were infected by HIV positive mothers”
The worldwide need for effective assessment and treatment is more urgent than ever, and Beckman Coulter is part of the solution. Beckman Coulter helped pioneer the use of flow cytometry to confront the emerging threat of HIV/AIDS in the 1980s. Beckman Coulter introduced the manual CD4 counting test for use with a microscope for labs without access to flow cytometry. At Beckman Coulter Diagnostics & Life Sciences, we are moving healthcare forward by bringing more than 80 years of automation and innovation history in the clinical diagnostics laboratory from Flow cytometry to the molecular diagnostics arena.
“Beckman Coulter supports the UNAIDS 90-90-90 target”
Beckman Coulter Joins the Fight
By focusing on innovative, yet affordable solutions for HIV monitoring, Beckman Coulter supports the UNAIDS 90-90-90 target to ensure that by the year 2020, 90% of people living with HIV will know their HIV status, 90% of people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 90% of all people receiving antiretroviral therapy will have viral suppression(2).
CARES Initiative topics
Uganda NHLS Lab Strengthening Pilot
Beckman Coulter Life Science and The CARES Initiative to fight HIV/AIDS has partnered with the Uganda National Health Laboratory Service within the Ministry of Health based in Kampala Uganda. The partnership was formed to support a laboratory strengthening Pilot. The Pilot will run 12 months.
New WHO Guidelines for HIV
New World Health Organization guidelines seek to find and protect those at greatest risk of advanced HIV disease. Counting the number of CD4 cells in a patient’s blood is the only accurate way of monitoring how well their immune system is working and predicting the progression of HIV.
HIV diagnosis up to four times faster
Africa’s poorest and most vulnerable can benefit from simple HIV test which monitors disease progression, enabling governments to deliver comprehensive treatment programs. Improving diagnostics in rural communities Prof Debbie Glencross is Director and Principle Pathologist.
1. WHO (2015): HIV/AIDS Fact Sheet No. 360. World Health Organization, Geneva.
2. UNAIDS (2014): 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, pp. 1-33.